Telehealth GLP-1 prescriptions
A women-focused telehealth platform founded in 2024 that prescribes compounded GLP-1 and GIP medication and brand-name Ozempic for weight loss, alongside hormone replacement therapy and longevity peptides such as NAD+ and sermorelin.
We may earn a commission if you buy through the links to Gala Health on this page, at no extra cost to you. That does not change how we grade or rank it, and Gala Health did not write or approve this review.
quality claims we could confirm ourselves, rather than repeat from the vendor's marketing.
Compounded GLP-1 and GIP medication including tirzepatide, brand-name Ozempic, estradiol and progesterone, NAD+ and sermorelin.
Everything here is a prescription service that starts with a licensed clinician's review of your own health information. Compounded medications are made by a pharmacy against a prescription and are not FDA-approved or reviewed by the FDA for safety, effectiveness or quality. This entry describes what the brand offers and what we could check. It is not medical advice and not a recommendation to use it.
Every telehealth brand we rank gets the same five checks, read from its public pages on September 24, 2026. "Not met" means we did not find it, or the terms say otherwise, on the pages we could read. Price and commission play no part.
The site shows $179 a month in one place and $199 on a 3-month plan in another.
Its terms name OpenLoop Healthcare Partners, Reliant.MD Medical Associates and MECNB Physician Services.
Refers to a partner pharmacy generically and names none.
Its refund policy says no refund on cancellation, apart from medical disqualification.
No warning letter under this name in FDA's public database on September 24, 2026.
Graded by whether we could confirm it ourselves or are only repeating what the vendor states. A vendor's honesty about its own testing is a different question from what a published trial shows, so this is a separate scale from the evidence grades on our guides.
The homepage says $179 per month for all doses. Elsewhere on the same site the GLP-1 range is described as starting at $199 per month on a 3-month plan. The two figures may describe different plans, but the page does not spell that out.
Where the vendor states thisStated on the homepage. State availability can differ by treatment, so check before starting intake. We confirmed this ourselves.
Where the vendor states thisThe site states this itself in its pricing copy, which is the correct framing.
Where the vendor states thisFDA does not review compounded drugs for safety, effectiveness or quality before they are sold. In 2026 FDA warned 30 telehealth companies over claims implying sameness with approved drugs, and proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list, so the legal footing of this category can change.
$179 per month and $199 per month on a 3-month plan are both shown. Confirm which applies to your dose and plan length.
The homepage says so. A second figure of $199 per month on a 3-month plan appears elsewhere, so confirm your plan before paying.
Every fact above traces to one of these pages, published by the vendor itself and checked on September 22, 2026. Vendor policy pages change without notice, so if something here looks out of date, it probably is.
Compare against
Open pricing, public COAs, strict research-only gate
